Skip to content

144Accepted Aug 21, 6:43 PM ET

ARS Pharmaceuticals, Inc. 144

ORBIMED CAPITAL LLC

Accepted (ET)

6:43 PM

Aug 21, 2024

Filed

Aug 21, 2024

Documents

1

Size

4.9 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.